Navigation Links
"Beach to Bedside" Study Focuses on Effects of Inhaled Toxins

Researchers at University of North Carolina Wilmington announce the continuation of funding to study the effects of inhaled Florida red tide brevetoxins and ultimately// yield treatments. The National Institute of Environmental Health Sciences awarded UNCW the five-year $7.53 million competitive renewal to further delve into the acute and chronic effects of inhaling toxic particles generated by red tides on Florida's west coast.

"Preliminary studies with red tide toxin have revealed four new non-toxic compounds that can improve the clearance of mucus from the lungs," said David A. Schwartz, M.D., director of the National Institute of Environmental Health Sciences. "This funding will enable these researchers to continue their evaluation of these compounds as potential therapeutic agents for the treatment of cystic fibrosis and similar lung diseases."

In addition to UNCW, project collaborators include the Centers for Disease Control and Prevention, the Florida Department of Health, Lovelace Respiratory Research Institute, Mote Marine Laboratories, the University of Miami Rosenstiel School of Marine and Atmospheric Science and Mount Sinai Medical Center of Miami Beach. The study seeks to confirm increased respiratory distress records in local emergency rooms, treatments and therapeutics for red tide inhalation intoxication that occurs on the beach, and to develop laboratory models that further refine and describe molecular mechanisms of action and therapeutics.

Daniel Baden, William R. Kenan Distinguished Professor of Marine Sciences at UNCW and program director for the study, said, "With an understanding of the molecular mechanisms of toxin action, we can recommend appropriate therapeutics for intervention and provide some measure of effects in humans. While it is not presently within our power to prevent red tides, it is certainly possible and advisable to reduce, treat and ultimately prevent inhalation exposure to these noxious ag ents."

This study is one of the most far-reaching and inclusive in the history of red tide research. Working together across disciplines, oceanographers, chemists, toxicologists, public health specialists, physicians and biomedical scientists approach the problem in a "beach to bedside" manner, emulating the "bench to bedside" mantra of current National Institutes of Health-funded research that leads to clinical intervention. By measuring red tide cells in the water, the toxin they contain, the airborne toxin in sea spray, the toxin transported ashore by wind and the amount people inhale, the team is rapidly increasing understanding about one of the most far-reaching human exposures to a natural toxin.

Florida red tide toxins affect the pulmonary, nervous, immune and genetic systems in animal models and may similarly affect humans. The study, beginning its sixth year, has presented its findings to the Society of Toxicology, to the International Society on Exposure Analysis, to the CDC and Florida DOH and to scientific and lay audiences alike. More than 80 published articles detail findings to date, and three patents dealing with seafood poisoning and pulmonary therapeutics have resulted from the work.

Source-Newswise
'"/>




Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... , ... December 05, 2016 , ... ... Plastic Surgery, is excited to announce the arrival of the newest Sciton laser ... with the ability to use tunable non-ablative and ablative wavelengths for exceptional results. ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., the leading ... magazine, a leading online tech news platform connecting technology innovators with news, experience, ... explores the state of enterprise mobility security today, and how the SyncDog SentinelSecure™ ...
(Date:12/5/2016)... ... 05, 2016 , ... Worldwise ®, a leading consumer ... kathy ireland® Worldwide for five additional years, announced by Kevin Fick, Worldwise CEO. ... agreement three years ago to design and develop the kathy ireland® Loved Ones™ ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... , Dec. 5, 2016 Special purpose needles are ... such as fluid and cells from organs or lumps and ... and sizes. The global market for special purpose needles is ... In terms of revenue, the global special purpose needles market ... the forecast period (2016–2026) and is expected to be valued ...
(Date:12/5/2016)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... 2 clinical study of sotagliflozin, a dual SGLT1 and ... the leading global organization funding type 1 diabetes research. ... trial, which randomized a total of 87 patients, was ... dose of sotagliflozin compared to a placebo control in ...
Breaking Medicine Technology: